Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2024-07-09 to 2024-07-10
Current total value of award: $79604.49
Description: 4565096455!XELJANZ XR 11 MG TABLET UU 30S